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Abstract 
   This 41-year-old man presented with exophthalmos and loss in visual acuity.  
Neuroradiological study showed a large mass from the intraorbital region to the 
frontal lobe; it also involved the middle cranial- and infratemporal fossa, and was 
accompanied by skull destruction.  The tumor was almost totally removed.  The 
histological diagnosis was sebaceous carcinoma with pagetoid changes.  
Despite surgery and local irradiation, intracranial metastases were recognized 
one year later and he underwent total removal and whole-brain irradiation.  
Although multiple lung metastases were detected one year after the 2nd operation, 
3 years after the surgery, he is free of intracranial recurrence.  Sebaceous 
carcinomas of meibomian gland origin with pagetoid changes are a distinct, highly 
aggressive clinical entity.  Early diagnosis and appropriate treatment are 
essential to improve the prognosis of patients with meibomian gland carcinoma 
with intracranial extension.
1. Introduction 
   Meibomian gland carcinomas of the eyelid are rare adnexal epithelial tumors 
and although local recurrence and lymph node metastasis are common, 
metastasis from skin tumors is not.1-3  Among meibomian gland carcinomas, 
32% recurred and 6% extended orbitally.4  To date, only 2 patients with 
intracranial progression have been reported.  We encountered a patient with 
highly aggressive meibomian gland carcinoma from the eyelid with intracranial 
and intraorbital progression. 
   Among the morphological features of sebaceous carcinomas of the 
meibomian gland, pagetoid involvement is important.3,4  We posit that in our 
patient extensive pagetoid spread in the epithelium was a major contributor to its 
aggressive behavior. 
2. Case Report 
   This 41-year-old man presented with exophthalmos, visual acuity loss and 
restricted left-eye movement.  He also manifested painless swelling of the left 
frontal region and the left upper eyelid was reddish.  No lesions were found in 
the skin or conjunctiva.  A computed tomography (CT) scan revealed an 
iso-dense mass extending from the orbital roof to the frontal convexity (Fig.1A,B).  
On gadolinium-enhanced T1- and T2-weighted magnetic resonance imaging 
(MRI), the signal from the mass was iso-intense (Fig. 1C-E). 
   At surgical exploration, the frontal and temporal bone around the area of skull 
destruction was drilled out to the base of the middle cranial fossa to expose the 
intact dura mater.  The exposed firm tumor was located in the extradural space 
and involved peripheral tissue.  Internal decompression of the tumor revealed 
an embedded fibrous round core seen as an iso-intense mass on T1- and 
T2-weighted images.  The tumor broke through the periorbita and invaded the 
intraconus space from the lateral side of the superior rectal muscle without 
involvement of extraocular muscles.  It extended from the parasellar region to 
the temporal base and infratemporal fossa, and was excised with a high-output 
cavitational ultrasonic surgical aspirator.  Because there was strong tumor 
attachment to the upper eyelid, it was thought to be the primary site.  We 
considered gross total resection with microsurgical procedures to have been 
successful. 
   Microscopic examination showed that many of the tumor cells were 
undifferentiated, invasive and mitotic.  We noted irregular lobular formations 
with fibrous septa and extensive pagetoid involvement of the epithelium (Fig. 2).  
The presence of vacuolated cytoplasm suggested sebaceous differentiation. 
   Postoperatively, his exophthalmos and eyeball movement were improved.  
We delivered 60-Gy local irradiation.  One year later we detected local 
recurrence and metastasis at the dura of the left frontal parasagittal region 
(Fig.3A,B).  He refused orbital exenteration.  We removed both tumors as a 
palliative procedure and delivered 40-Gy whole-brain irradiation.  One year 
after the 2nd operation, multiple lung metastases were found (Fig.3C).  
Histological study of needle biopsy specimens returned results identical to those 
of the previously obtained surgical specimens and he received chemotherapy.  
There has been no intracranial recurrence in the course of 3 years after his 2nd 
operation.
3. Discussion 
   The intracranial extension of meibomian gland carcinoma is extremely rare 
and only 2 cases have been reported to-date.4  One was an autopsy case with 
tumor extension to the trigeminal ganglia and metastasis to the cerebellum.5  In 
the other case, the tumor invaded the frontal bone and adjacent dura. 2 
  In the course of malignant changes of the sebaceous gland, normal cell 
maturation is replaced by undifferentiated cells.  The tumor cells are 
pleomorphic with round or polyhedral nuclei, prominent nucleoli, and vacuolated 
cytoplasm.  Sebaceous carcinoma with pagetoid involvement is associated with 
a higher mortality rate,3 among patients with- and without pagetoid involvement it 
was approximately 50% and 10%, respectively.1 
  Pagetoid spread is of diagnostic and prognostic significance, rendering this 
tumor a distinct and highly aggressive clinical entity.6  Although our patient did 
not manifest pagetoid spread to the skin or conjunctiva, it is commonly seen in 
sebaceous carcinoma and is usually found in the conjunctiva.  Among 3 
patients with sebaceous carcinomas with intracranial extension, including ours, 2 
manifested pagetoid changes.  We posit that this change is reflective of the 
aggressive behavior, intracranial extension with skull destruction, recurrence 
and distal metastasis from these tumors. 
    Among malignant eyelid tumors reported in Western countries, sebaceous 
cell carcinoma is rare.  On the other hand, it is one of the most common 
malignant eyelid tumors among Asian populations where it is almost as common 
as basal cell carcinoma.7-9  Jahaqirdar et al.2 reported that 80-90% of eyelid 
malignancies in Caucasians were basal cell carcinoma and patients with basal 
cell carcinoma had a better prognosis.  Because the mortality rate among 
patients with sebaceous cell carcinoma is high, these cancers should be treated 
aggressively.10  There is also an association of sebaceous cell carcinoma with 
the inherited (autosomal dominant) Muir-Torre syndrome, where multiple visceral 
tumors, mainly colon cancer, may arise.11  Wang et al.12 suggested that 
inactivation of the fragile histidine triad tumor suppressor gene or inactivation of 
the mismatch-repair system resulting in microsatellite instability may contribute 
to the development of Muir-Torre syndrome.12 
   Currently, the only effective therapy for sebaceous carcinoma of meibomian 
gland origin is radical surgery.2,3,13  Orbital exenteration has been 
recommended if there is clinical and neuroradilogical evidence of intraorbital 
extension.1,3,5  Because our patient rejected this course we delivered, additional 
irradiation although there is no consensus regarding this treatment modality as 
adjuvant therapy.  In some cases, irradiation was thought to be effective 
although pathologic studies disclosed extensive irradiation-induced 
degenerative changes.3,4,14  While the effective treatment of patients with 
intracranial extension from meibomian gland carcinoma remains difficult and 
their prognosis poor, a reduction in the tumor mortality rate requires early 
recognition and appropriate aggressive treatment.2,3 
References 
1. Rao NA, Hidayat AA, McLean IW et al., Sebaceous carcinomas of the ocular 
adnexa: A clinicopathologic study of 104 cases, with five years follow-up data. 
Hum Pathol 13(1982), pp.113-122. 
2. Colak A, Akkurt C, Ozcan OE et al., Intracranial extension of meibomian gland 
carcinoma. J Clin Neuroophthalmol 11(1991), pp.39-42. 
3. Doxanes TM and Green RW, Sebaceous gland carcinoma. Review of 40 
cases. Arch Opththalmol 102(1984), pp.245-249. 
4. Ginsburg J, Present status of meibomian gland carcinoma. Arch Ophthalmol 
73(1965)73, pp.271-277. 
5. Bryant J, Meibomian gland carcinoma seeding intracranial soft tissues. Hum 
Pathol 8(1977), pp.455-457. 
6. Russell WG, Page DL, Hough JA et al., Sebaceous carcinoma of meibomian 
gland origin. The diagnostic importance of pagetoid spread of neoplastic cells. 
Am J Clin Pathol 73(1980), pp.504-511. 
7. Demirci H, Nelson CC, Shields CL et al., Eyelid sebaceous carcinoma 
associated with Muir-Torre syndrome in two cases. Ophthal Plast Reconstr Surg 
23(2007), pp.77-79 
8. Holbach LM, von Moller A, Decker C et al., Loss of fragile histidine triad (FHIT) 
expression and microsatellite instability in periocular sebaceous carcinoma in 
patients with Muir-Torre syndrome. Am J Ophthalomol 134(2002), pp.147-148 
9. Jahaqirdar SS, Thakre TP, Kale SM et al. A clinicopathological study of eyelid 
malignancies from central India. Indian J Ophthalmol 55(2007), pp109-112 
10. Pornpanich K, Chindasub P. Eyelid tumors in Siriraj Hospital from 2000-2004. 
J Med Assoc Thai 88(2005), ppS11-14 
11. Takamura H, Yamashita H. Clinicopathological analysis of malignant tumor 
cases at Yamagata University Hospital: Statistical comparison of tumor 
incidence in Japan and in other countries. Jpn J Ophthalmol 49(2005), 
pp349-354 
12. Wang JK, Liao SL, Jou JR et al., Malignant eyelid tumours in Taiwan. Eye 
17(2003), pp216-220 
13. Khalil MK and Lorenzetti HD, Sebaceous gland carcinoma of the lid. Can J 
Ophthalmol 15(1990), pp.117-121. 
14. Ide CH, Ridings GR, Yamashita T et al., Radiotherapy of a recurrent 




Preoperative plain- (A) and bone-window CT (B) scan showing an isodense 
mass with extension into the intraorbital and intracranial space (arrow).  C. 
Preoperative T1-weighted MRI without contrast enhancement showed an 
isointense mass invading the intraorbital and intracranial space and skull 
destruction.  D. T2-weighted MRI showing an isointense mass that included a 
small round isointense mass with a hypointense rim.  E. Contrast-enhanced 
T1-weighted MRI showing enhancement of the tumor.  During surgery we found 
that the unenhanced, round, iso-intense area was a fibrous mass embedded in 
the tumor. 
Figure 2 
Photomicrographs of the surgical specimen.  A. The diagnosis of sebaceous 
carcinoma of the meibomian gland was confirmed histologically.  Many tumor 
cells were undifferentiated, invasive and mitotic.  Note the irregular lobular 
formations with fibrous septa (H&E, original magnification x100).  B. The tumor 
cells showed typical pagetoid involvement in the epithelium with vacuolated 
cytoplasm, suggestive of sebaceous differentiation (H&E, original magnification 
x 400). 
Figure 3 
A. Contrast-enhanced, fat-suppressed MRI obtained one year after the 1st 
operation.  There is local tumor recurrence in the left frontal region (arrow).  B. 
Contrast-enhanced T1-weighted MRI revealed remote intracranial tumor 
recurrence in the dura of the left frontal parasagittal region.  C. Chest X-ray 




CT: computed tomography, MRI: magnetic resonance imaging 



